NO20056020L - Smapartiklet farmasoytisk formulering av midler mot anfall og demens, og immunsuppresjonsmidler - Google Patents
Smapartiklet farmasoytisk formulering av midler mot anfall og demens, og immunsuppresjonsmidlerInfo
- Publication number
- NO20056020L NO20056020L NO20056020A NO20056020A NO20056020L NO 20056020 L NO20056020 L NO 20056020L NO 20056020 A NO20056020 A NO 20056020A NO 20056020 A NO20056020 A NO 20056020A NO 20056020 L NO20056020 L NO 20056020L
- Authority
- NO
- Norway
- Prior art keywords
- immunosuppressants
- smaparticle
- antidepressant
- pharmaceutical formulation
- dementia agents
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 229960003444 immunosuppressant agent Drugs 0.000 title abstract 2
- 239000003018 immunosuppressive agent Substances 0.000 title abstract 2
- 206010012289 Dementia Diseases 0.000 title 1
- 230000001430 anti-depressive effect Effects 0.000 title 1
- 239000000935 antidepressant agent Substances 0.000 title 1
- 229940005513 antidepressants Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
- 229930105110 Cyclosporin A Natural products 0.000 abstract 1
- 108010036949 Cyclosporine Proteins 0.000 abstract 1
- 229940125681 anticonvulsant agent Drugs 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 abstract 1
- 229960000623 carbamazepine Drugs 0.000 abstract 1
- 229960001265 ciclosporin Drugs 0.000 abstract 1
- 229930182912 cyclosporin Natural products 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47158103P | 2003-05-19 | 2003-05-19 | |
| PCT/US2004/015621 WO2004103348A2 (fr) | 2003-05-19 | 2004-05-19 | Preparations pharmaceutiques de petites particules d'anticonvulsivants et d'agents contre la demence et agents immmunosupresseurs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20056020L true NO20056020L (no) | 2005-12-16 |
Family
ID=33476859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20056020A NO20056020L (no) | 2003-05-19 | 2005-12-16 | Smapartiklet farmasoytisk formulering av midler mot anfall og demens, og immunsuppresjonsmidler |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050244503A1 (fr) |
| EP (1) | EP1628641A2 (fr) |
| JP (1) | JP2006528985A (fr) |
| KR (1) | KR20060012628A (fr) |
| CN (1) | CN1791386A (fr) |
| AU (1) | AU2004240640A1 (fr) |
| BR (1) | BRPI0410767A (fr) |
| CA (1) | CA2524538A1 (fr) |
| MX (1) | MXPA05012467A (fr) |
| NO (1) | NO20056020L (fr) |
| WO (1) | WO2004103348A2 (fr) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4484247B2 (ja) * | 1995-02-24 | 2010-06-16 | エラン ファーマ インターナショナル，リミティド | ナノ粒子分散体を含有するエアロゾル |
| EP2266542A3 (fr) * | 1998-10-01 | 2013-07-31 | Elan Pharma International Limited | Libération regulée de compositions nanoparticulaires |
| US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
| US20050048126A1 (en) | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| US7193084B2 (en) | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
| US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
| BR0212833A (pt) | 2001-09-26 | 2004-10-13 | Baxter Int | Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida |
| EP1471887B1 (fr) | 2002-02-04 | 2010-04-21 | Elan Pharma International Ltd. | Compositions nanoparticulaires a stabilisateur superficiel de lysozyme |
| WO2004078162A1 (fr) * | 2003-01-31 | 2004-09-16 | Elan Pharma International Ltd. | Formulations contenant des nanoparticules de topiramate |
| US20040208833A1 (en) * | 2003-02-04 | 2004-10-21 | Elan Pharma International Ltd. | Novel fluticasone formulations |
| AU2004249172A1 (en) * | 2003-06-24 | 2004-12-29 | Baxter International Inc. | Specific delivery of drugs to the brain |
| US8986736B2 (en) * | 2003-06-24 | 2015-03-24 | Baxter International Inc. | Method for delivering particulate drugs to tissues |
| US7824697B2 (en) | 2004-07-12 | 2010-11-02 | Board Of Regents, The University Of Texas System | High concentration baclofen preparations |
| CA2590675A1 (fr) * | 2004-12-15 | 2006-06-22 | Elan Pharma International Ltd. | Formulations renfermant des nanoparticules de tacrolimus |
| MX2007011494A (es) * | 2005-03-17 | 2007-12-06 | Elan Pharma Int Ltd | Composiciones inyectables de compuestos inmunosupresores nanoparticulados. |
| AU2006235487B2 (en) * | 2005-04-12 | 2011-12-22 | Elan Pharma International Limited | Nanoparticulate quinazoline derivative formulations |
| AU2006235478B2 (en) * | 2005-04-12 | 2011-07-21 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising cyclosporine |
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| BRPI0600285C1 (pt) * | 2006-01-13 | 2011-10-11 | Brz Biotecnologia Ltda | compostos farmacêuticos contendo nanopartìculas úteis para tratamento de lesões reestenóticas |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
| US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
| AU2008279129A1 (en) * | 2007-07-24 | 2009-01-29 | Nexbio, Inc. | Technology for the preparation of microparticles |
| RU2496482C2 (ru) * | 2008-03-05 | 2013-10-27 | Бакстер Интернэшнл Инк. | Композиции и способы для доставки лекарственных средств |
| US8969414B2 (en) * | 2009-02-06 | 2015-03-03 | Mallinckrodt Llc | Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products |
| US20150258279A1 (en) | 2008-03-18 | 2015-09-17 | Mallinckrodt Llc | Intrathecal baclofen pharmaceutical dosage forms and related delivery system |
| US10952965B2 (en) * | 2009-05-15 | 2021-03-23 | Baxter International Inc. | Compositions and methods for drug delivery |
| PE20121359A1 (es) | 2009-12-10 | 2012-10-15 | Merck Patent Gmbh | Composicion farmaceutica que comprende oligopeptidos |
| US10307372B2 (en) * | 2010-09-10 | 2019-06-04 | The Johns Hopkins University | Rapid diffusion of large polymeric nanoparticles in the mammalian brain |
| EP2717854B1 (fr) | 2011-06-09 | 2019-01-16 | Merck Patent GmbH | Traitement de cancers et de métastases à l'aide de suspensions de cilengitide dans un véhicule |
| US20140178479A1 (en) | 2011-08-12 | 2014-06-26 | Perosphere, Inc. | Concentrated Felbamate Formulations for Parenteral Administration |
| EP2866792A4 (fr) | 2012-06-28 | 2016-08-17 | Ansun Biopharma Inc | Formulations de microparticules pour la délivrance au système respiratoire inférieur et central et procédés de fabrication |
| AU2013351934B2 (en) * | 2012-11-30 | 2018-03-29 | Insmed Incorporated | Prostacylin compositions and methods for using the same |
| ES2860975T3 (es) | 2013-10-25 | 2021-10-05 | Insmed Inc | Compuestos de prostaciclina |
| AU2015349969B2 (en) | 2014-11-18 | 2020-02-06 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
| AU2016338672A1 (en) * | 2015-10-16 | 2018-04-12 | Marinus Pharmaceuticals, Inc. | Injectable neurosteroid formulations containing nanoparticles |
| EP3612186A1 (fr) * | 2017-04-18 | 2020-02-26 | Marinus Pharmaceuticals, Inc. | Formulations de neurostéroïde injectables à libération prolongée |
| WO2019186515A1 (fr) * | 2018-03-30 | 2019-10-03 | Ftf Pharma Private Limited | Compositions pharmaceutiques liquides de médicaments anti-épileptiques |
| US12496279B2 (en) | 2019-04-11 | 2025-12-16 | The Johns Hopkins University | Nanoparticles for drug delivery to brain |
| CN114072136B (zh) | 2019-04-29 | 2024-11-29 | 英斯梅德股份有限公司 | 曲前列素前药的干粉组合物及其使用方法 |
| EP4188358A2 (fr) * | 2020-07-31 | 2023-06-07 | Pan-Montojo, Francisco | Combinaison pharmaceutique comprenant de l'acide glycolique et de la l-alanine |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2948718A (en) * | 1960-08-09 | New n-heterocyclic compounds | ||
| US4608278A (en) * | 1983-06-22 | 1986-08-26 | The Ohio State University Research Foundation | Small particule formation and encapsulation |
| US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
| CA1338736C (fr) * | 1986-12-05 | 1996-11-26 | Roger Baurain | Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation |
| FR2608988B1 (fr) * | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules |
| FR2651680B1 (fr) * | 1989-09-14 | 1991-12-27 | Medgenix Group Sa | Nouveau procede de preparation de microparticules lipidiques. |
| US5188837A (en) * | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
| GB9024366D0 (en) * | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US5720551A (en) * | 1994-10-28 | 1998-02-24 | Shechter; Tal | Forming emulsions |
| SE9403846D0 (sv) * | 1994-11-09 | 1994-11-09 | Univ Ohio State Res Found | Small particle formation |
| US5665331A (en) * | 1995-01-10 | 1997-09-09 | Nanosystems L.L.C. | Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers |
| US5560932A (en) * | 1995-01-10 | 1996-10-01 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents |
| US5716642A (en) * | 1995-01-10 | 1998-02-10 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents |
| US5662883A (en) * | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
| US6143211A (en) * | 1995-07-21 | 2000-11-07 | Brown University Foundation | Process for preparing microparticles through phase inversion phenomena |
| ATE252372T1 (de) * | 1996-08-23 | 2003-11-15 | Sequus Pharm Inc | Liposome enthaltend cisplatin |
| CA2277801C (fr) * | 1997-01-16 | 2002-10-15 | Massachusetts Institute Of Technology | Preparation de particules pour inhalation |
| ATE318132T1 (de) * | 1998-03-30 | 2006-03-15 | Jagotec Ag | Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung |
| ATE228823T1 (de) * | 1998-04-18 | 2002-12-15 | Glaxo Group Ltd | Pharmazeutische aerosolformulierung |
| US6270806B1 (en) * | 1999-03-03 | 2001-08-07 | Elan Pharma International Limited | Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
| DK1169019T3 (da) * | 1999-04-14 | 2003-06-02 | Glaxo Group Ltd | Farmaceutisk aerosolformulering |
| US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US6951656B2 (en) * | 2000-12-22 | 2005-10-04 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
| US20060003012A9 (en) * | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
-
2004
- 2004-05-19 CA CA002524538A patent/CA2524538A1/fr not_active Abandoned
- 2004-05-19 BR BRPI0410767-5A patent/BRPI0410767A/pt not_active IP Right Cessation
- 2004-05-19 AU AU2004240640A patent/AU2004240640A1/en not_active Abandoned
- 2004-05-19 US US10/848,765 patent/US20050244503A1/en not_active Abandoned
- 2004-05-19 KR KR1020057021987A patent/KR20060012628A/ko not_active Withdrawn
- 2004-05-19 MX MXPA05012467A patent/MXPA05012467A/es not_active Application Discontinuation
- 2004-05-19 CN CNA200480013787XA patent/CN1791386A/zh active Pending
- 2004-05-19 EP EP04752612A patent/EP1628641A2/fr not_active Withdrawn
- 2004-05-19 WO PCT/US2004/015621 patent/WO2004103348A2/fr not_active Ceased
- 2004-05-19 JP JP2006533204A patent/JP2006528985A/ja not_active Withdrawn
-
2005
- 2005-12-16 NO NO20056020A patent/NO20056020L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2524538A1 (fr) | 2004-12-02 |
| MXPA05012467A (es) | 2006-02-22 |
| AU2004240640A1 (en) | 2004-12-02 |
| US20050244503A1 (en) | 2005-11-03 |
| CN1791386A (zh) | 2006-06-21 |
| EP1628641A2 (fr) | 2006-03-01 |
| WO2004103348A2 (fr) | 2004-12-02 |
| JP2006528985A (ja) | 2006-12-28 |
| WO2004103348A3 (fr) | 2005-01-06 |
| KR20060012628A (ko) | 2006-02-08 |
| BRPI0410767A (pt) | 2006-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20056020L (no) | Smapartiklet farmasoytisk formulering av midler mot anfall og demens, og immunsuppresjonsmidler | |
| DE602006017579D1 (de) | Klebstoff für optischen film sowie von dem klebstoff gebrauch machendes klebevlies und optisches glied | |
| LTPA2018502I1 (lt) | Per burną vartojamos kladribino kompozicijos | |
| AU305551S (en) | Bottle | |
| AU305158S (en) | Bottle | |
| DE602005018825D1 (de) | Verpackung für rauchwaren und dergleichen | |
| ATE381893T1 (de) | Aromapartikel | |
| DE602005027546D1 (de) | Aryl- und heteroarylpiperidincarboxylatderivate, deren herstellung und deren verwendung in form von faah-enzyminhibitoren | |
| AU305027S (en) | Bottle | |
| IL186102A0 (en) | Alpha ketoamide derivatives and pharmaceutical compositions containing the same | |
| NO20051281D0 (no) | Sammensetning for anrikning av naeringsmidler | |
| DK1667668T3 (da) | Alfabeta3 og altabeta6-integrinantagonister som antifibrotiske midler | |
| DE602004015741D1 (de) | Parfumteilchen und das Verfahren zu deren Herstellung | |
| ITRM20050589A1 (it) | Accessorio da tavolo per il supporto di borse e simili. | |
| ITFI20020038A1 (it) | Coloranti ceramici in forma di sospensioni nanometriche | |
| DE60334632D1 (de) | Mechanolumineszenzstoff und dessen herstellung | |
| ITTO20040434A1 (it) | Confezione multipla di buste contenenti prodotti ad uso medicale. | |
| FR2846327B1 (fr) | Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant. | |
| EP1734116A4 (fr) | Derives de thrombine et compositions medicinales en contenant | |
| IL191560A0 (en) | 3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same | |
| ATE487706T1 (de) | Cyclische n-ä1,3,4ü-thiadiazol-2-yl- benzsulfonamide, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| ITBO20060237A1 (it) | Metodo e macchina per l'incarto di articoli. | |
| ITMI20051043A1 (it) | "apparato e metodo per l'esplorazione di oggetti grafici per utenti". | |
| RU2004132147A (ru) | Адаптоген | |
| BR0306305B1 (pt) | palete, mÉtodo para formar o mesmo, e, artigo de suporte. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |